Drug Sponsors

Pfizer, Mylan ink exclusive long-term collaboration for generics in Japan

Thursday, August 23, 2012 02:02 PM

Global research-based pharmaceutical company Pfizer and Canonsburg, Penn.-based pharmaceutical company Mylan have signed a definitive agreement to establish an exclusive long-term strategic collaboration to develop, manufacture, distribute and market generic drugs in Japan.

More... »

Transgenomic awarded NIH STTR grant for pancreatic cancer research

Thursday, August 23, 2012 11:15 AM

Transgenomic,an Omaha, Neb.-based global biotechnology company focused on personalized medicine, has been awarded a $100,000 Small Business Technology Transfer Program (STTR) phase I grant by the National Institutes of Health’s National Center For Advancing Translational Sciences.

More... »

West Pharma breaks ground on new manufacturing facility in India

Thursday, August 23, 2012 10:46 AM

West Pharmaceutical India Packaging, an indirect subsidiary of West Pharmaceutical Services, began construction of its new compression molding facility located in Sri City, India.

More... »

Proteonomix licenses exclusive worldwide rights to novel anti-tumor technology

Thursday, August 23, 2012 10:19 AM

Proteonomix, a Hawthorne, N.J.-based biotechnology company focused therapeutics based upon the use of human cells and their derivatives, has entered into an exclusive worldwide license agreement for a novel source of primary human cells that secrete a factor capable of inhibiting tumor cell growth and causing tumor cell death.

More... »

EMD Millipore to acquire Biochrom

Thursday, August 23, 2012 09:54 AM

EMD Millipore, the life science division of Merck of Darmstadt, Germany, has decided to acquire Biochrom, a cell culture media specialist of Berlin, Germany. The closing price was not disclosed.

More... »

MiReven, Silence to evaluate delivery of novel microRNA-based therapeutics

Wednesday, August 22, 2012 02:05 PM

Silence Therapeutics, an RNA interference (RNAi) therapeutics company, has signed an agreement with MiReven, an Australian-based microRNA company, to assess the delivery potential of Silence's proprietary delivery systems with MiReven's novel microRNA-based therapeutics.

More... »

Marina Biotech reduces board size, seeks funding

Wednesday, August 22, 2012 01:35 PM

Marina Biotech, a nucleic acid-based drug discovery and development company, continues to seek adequate funding to implement its business plan.

More... »

AIDS Healthcare Foundation acquires MOMS Pharmacy

Wednesday, August 22, 2012 10:44 AM

AIDS Healthcare Foundation (AHF), a global nonprofit HIV/AIDS organization has acquired MOMS Pharmacy, a specialty pharmacy focused exclusively on providing medications and support services to people living with HIV/AIDS.

More... »

South and Central America API market closing gap on northern neighbors

Wednesday, August 22, 2012 09:57 AM

More... »

Ipsen, Inspiration Biopharmaceuticals renegotiate strategic partnership

Tuesday, August 21, 2012 12:15 PM

Ipsen, a global specialty-driven pharmaceutical company, has renegotiated its 2010 strategic partnership agreement with Inspiration Biopharmaceuticals, a Cambridge, Mass.-based biopharmaceutical company focused on hemophilia, for the development and commercialization of Inspiration’s recombinant product portfolio.

More... »